Friday, March 20, 2015 1:36:07 PM
Recent PRTA News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2024 10:58:06 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2024 10:57:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2024 08:13:21 PM
- Prothena Announces Leadership Team Updates • Business Wire • 09/27/2024 08:05:00 PM
- Prothena to Participate in Upcoming Healthcare Conferences • Business Wire • 08/29/2024 08:05:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/08/2024 09:13:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:14:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:09:02 PM
- Prothena Reports Second Quarter 2024 Financial Results and Business Highlights • Business Wire • 08/08/2024 08:05:00 PM
- Prothena to Report Second Quarter 2024 Financial Results on August 8 • Business Wire • 08/01/2024 08:05:00 PM
- Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration • Business Wire • 05/28/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 08:42:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 08:37:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 08:29:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:08:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:19:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:09:01 PM
- Prothena Reports First Quarter 2024 Financial Results and Business Highlights • Business Wire • 05/08/2024 08:05:00 PM
- Prothena to Report First Quarter 2024 Financial Results on May 8 • Business Wire • 05/01/2024 08:05:00 PM
- Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma • Business Wire • 04/15/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 02:03:16 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 02:01:40 AM
- Prothena to Participate in Upcoming Healthcare Conferences • Business Wire • 03/05/2024 09:05:00 PM
- Prothena Appoints David Ford to Newly Created Chief People Officer Position • Business Wire • 03/04/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 02:11:54 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM